Erin Podolak, MA

St. Jude scientists are fueling progress by studying the molecular groups of different cancers.

Scientists at St. Jude Children’s Research Hospital are deploying genomic technologies to hunt for vulnerabilities in cancer.

St. Jude scientists have learned that bacteria are more successful at developing antibiotic resistance when they swap genes through recombination.

A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.

Microcephaly is a rare neurodevelopmental condition in which a baby’s head is much smaller than expected because the brain did not develop properly or stopped developing during pregnancy. St. Jude researchers identified cells in the outer radial glia in the developing brain that play an important role in microcephaly.

The incidence of pediatric and adult liver cancer is increasing worldwide. Research suggests how premature birth may influence the risk for children.

Stimulating the adaptive immune response can improve outcomes for ALL treated with chemotherapy.

St. Jude research has advanced understanding of the immune response to SARS-CoV-2 infection and vaccination. Here is what the findings mean for you.

What lessons can be learned from the remarkable success of SAFER Ukraine?

Muscle signaling provide clues for treatment of the muscle-wasting disorder cachexia, which affects cancer patients.